AlaMab Therapeutics (Shanghai) Inc.
3 clinical trials · Sponsor
◉ Watch AlaMab Therapeutics (Shanghai) Inc.
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Efficacy of ALMB-0168 in Solid Tumor Patients With Bone Metastatic Whose Prior Standard Treatment Have Failed (NCT06416358) | AlaMab Therapeutics (Shanghai) Inc. | 2024-05-01 |
| Study to Evaluate the Safety and Pharmacokinetics of ALMB-0166 in Patients With Acute Spinal Cord Injury (NCT05524103) | AlaMab Therapeutics (Shanghai) Inc. | 2022-04-15 |
| A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With Osteosarcoma (NCT04886765) | AlaMab Therapeutics (Shanghai) Inc. | 2021-05-01 |
Track AlaMab Therapeutics (Shanghai) Inc. automatically
Every clearance here is in the API, with alerts when new ones post.